Gynecologic and reproductive health in patients with pathogenic germline variants in DICER1.
Merideth MA, Harney LA, Vyas N, Bachi A, Carr AG, Hill DA, Dehner LP, Schultz KAP, Stewart DR, Stratton P.
Gynecol Oncol. 2020 Mar;156(3):647-653. doi: 10.1016/j.ygyno.2019.12.037. Epub 2020 Jan 15.
PMID:31952842
The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
Durieux E, Descotes F, Mauduit C, Decaussin M, Guyetant S, Devouassoux-Shisheboran M.
Virchows Arch. 2016 May;468(5):631-6. doi: 10.1007/s00428-016-1922-0. Epub 2016 Mar 16.
PMID:26983701
Sertoli-Leydig cell tumor, thyroid follicular carcinoma and rhabdomyosarcoma of the uterine cervix in a prepubertal girl with pathogenic germline variant in DICER1 gene.
Karnak İ, Ceylan AC, Haliloğlu M, Özön A, Orhan D, Kutluk T.
Turk J Pediatr. 2021;63(3):500-505. doi: 10.24953/turkjped.2021.03.018.
PMID:34254496
Clinical heterogeneity and reduced penetrance in DICER1 syndrome: a report of three families.
Azzollini J, Ferrari A, Stracuzzi A, Chiaravalli S, Terenziani M, Spreafico F, Grasso M, Collini P, Pensotti V, Massimino M, Arbustini E, Manoukian S.
Tumori. 2021 Dec;107(6):NP144-NP148. doi: 10.1177/03008916211058788. Epub 2021 Nov 11.